Supradent Drugs Limited - Company Profile

It is a chemicals public limited company based in Dharmapuri, Tamil Nadu, India, established in 2008.
2008 Dharmapuri, Tamil Nadu, India Active
Last Updated:
Access Report
About Supradent Drugs Limited

Supradent Drugs Limited, a active public limited company, was established on 23 June 2008 in Dharmapuri, Tamil Nadu, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230TZ2008PLC017228. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.07 M.

It upholds a active non-compliant status. Its leadership includes Venkatesan Goppi (Managing Director), Radhakrishnan Venu Murali (Director), Nallakannu Baskara Prabakar (Director). Past directors included Mohamed Sakul Hamid, Radhakrishnan Venu Murali. It holds ₹3.00 M open charges and no settled loans. Its latest AGM occurred on 29 September 2012, with the balance sheet filed on 31 March 2012. It is based at 15/3 South Narasimachary Street, Dharmapuri, Tamil Nadu, 636701.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TZ2008PLC017228

  • Registration Number

    017228

  • Incorporation Date

    23 June 2008

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹1.07 M

  • ROC Code

    Roc Coimbatore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.07 M
  • Company Age 17 Year, 8 Months
  • Last Filing with ROC 31 Mar 2012
  • Open Charges ₹ 3.00 M
Company report

Supradent Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Supradent Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Supradent Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Venkatesan Goppi Managing Director 23 Jun 2008 Current
Radhakrishnan Venu Murali Director 01 Jun 2009 Current
Nallakannu Baskara Prabakar Director 23 Jun 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Jul 2011 Past
Pramod Abcsdd Director 03 Aug 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supradent Drugs.

Enhance accessibility to Supradent Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Supradent Drugs revenue growth over time
Supradent Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supradent Drugs?

Unlock access to Supradent Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Bank : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
14 Oct 2011 Indian Bank ₹3.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Supradent Drugs?

Unlock and access historical data on people associated with Supradent Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supradent Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supradent Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supradent Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Supradent Drugs Limited last Annual general meeting of members was held on 29 Sep 2012 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Supradent Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Coimbatore. was completed.

  • Charges

    Progress on A charge with Indian Bank amounted to Rs. 3.00 M with Charge ID 10317206 was registered on 14 Oct 2011. was documented.

  • Director Appointment

    Progress on Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 01 Jun 2009 & has been associated with this company since 16 years 9 months . was documented.

  • Director Appointment

    The activity Venkatesan Goppi was appointed as a Managing Director was appointed as a Managing Director on 23 Jun 2008 & has been associated with this company since 17 years 8 months . was completed.

  • Director Appointment

    Nallakannu Baskara Prabakar was appointed as a Director was appointed as a Director on 23 Jun 2008 & has been associated with this company since 17 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Supradent Drugs Limited?

The CIN of Supradent Drugs Limited is U24230TZ2008PLC017228.

Where is Supradent Drugs Limited headquartered?

Supradent Drugs Limited is headquartered at 15/3 South Narasimachary Street, Dharmapuri, Tamil Nadu, 636701.

When was Supradent Drugs Limited incorporated?

Supradent Drugs Limited was incorporated on 23 June 2008.

Who are the current directors of Supradent Drugs Limited?

The current directors of Supradent Drugs Limited are

What is the primary industry of Supradent Drugs Limited?

The primary industry of Supradent Drugs Limited is Chemicals.

Is Supradent Drugs Limited a listed company?

Supradent Drugs Limited is unlisted.

What is the capital structure of Supradent Drugs Limited?

The authorized capital of Supradent Drugs Limited is ₹2.50 M, and the paid-up capital is ₹1.07 M.

What is the compliance status of Supradent Drugs Limited?

The compliance status of Supradent Drugs Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available